Recent findings on the role of wild-type and mutant p53 in cancer development and therapy
Mehregan Babamohamadi(University of Tabriz), Goran Othman(Sulaimani Polytechnic University), Esmaeil Babaei(University of Tabriz), Mahshid Babamohammadi(Tabriz University of Medical Sciences), Hewa Jalal Azeez(University of Tabriz), Burhan Ahmed Salih(Sulaimani Polytechnic University)
Cited by 31
Related Papers
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
|Cell Death and Disease|2024|83
Types of RNA therapeutics
|Progress in molecular biology and translational science|2024|14
Phytostilbenes in lymphoma: Focuses on the mechanistic and clinical prospects of resveratrol, pterostilbene, piceatannol, and pinosylvin
|Leukemia Research|2024|14
Recent advances in targeting LRRK2 for Parkinson’s disease treatment
|Journal of Translational Medicine|2025|14
NO: a key player in microbiome dynamics and cancer pathogenesis
|Frontiers in Cellular and Infection Microbiology|2025|3